Vitalis Ventures has invested $15 million in Drive Health to enhance “Avery,” an AI-driven clinical workflow automation platform. Unlike traditional chatbots, Avery functions as a “clinical workflow engine,” designed to manage tasks such as discharge coordination and symptom monitoring while maintaining human oversight. This funding elevates Drive Health’s total capital to over $26 million as it prepares for a Series A funding round in 2026 and expands real-world applications, including a maternal health initiative in Illinois.
Avery distinguishes itself from generative AI by focusing on achieving specific goals. It seamlessly integrates into clinical workflows, allowing healthcare professionals to offload administrative tasks. Importantly, it operates under strict safety measures, employing a “human-in-the-loop” approach and adhering to hospital-defined guidelines.
Powered by Google’s robust infrastructure, Avery supports communication in over 15 languages and is currently playing a critical role in enhancing maternal health initiatives for underserved communities in Illinois.
Source link
